AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 156 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,314,000 | +257.1% | 125,235 | +73.2% | 0.00% | +200.0% |
| Q2 2020 | $1,208,000 | +46.2% | 72,311 | +26.2% | 0.00% | 0.0% |
| Q1 2020 | $826,000 | -73.2% | 57,308 | -37.9% | 0.00% | -50.0% |
| Q4 2019 | $3,087,000 | +76.0% | 92,232 | +10.1% | 0.00% | +100.0% |
| Q3 2019 | $1,754,000 | +59.7% | 83,778 | +58.9% | 0.00% | 0.0% |
| Q2 2019 | $1,098,000 | +33.4% | 52,738 | +43.3% | 0.00% | 0.0% |
| Q1 2019 | $823,000 | +20.5% | 36,802 | +28.9% | 0.00% | 0.0% |
| Q4 2018 | $683,000 | -9.4% | 28,551 | +3.4% | 0.00% | 0.0% |
| Q3 2018 | $754,000 | -14.8% | 27,623 | -16.0% | 0.00% | 0.0% |
| Q2 2018 | $885,000 | -4.1% | 32,900 | +13.4% | 0.00% | 0.0% |
| Q1 2018 | $923,000 | -27.1% | 29,000 | -13.4% | 0.00% | 0.0% |
| Q4 2017 | $1,266,000 | +63.8% | 33,476 | +7.4% | 0.00% | 0.0% |
| Q3 2017 | $773,000 | +34.2% | 31,183 | +11.3% | 0.00% | 0.0% |
| Q2 2017 | $576,000 | -39.4% | 28,007 | -35.9% | 0.00% | 0.0% |
| Q1 2017 | $950,000 | -36.6% | 43,720 | -40.3% | 0.00% | -50.0% |
| Q4 2016 | $1,499,000 | +105.9% | 73,279 | +50.9% | 0.00% | +100.0% |
| Q3 2016 | $728,000 | +39.5% | 48,546 | +0.6% | 0.00% | 0.0% |
| Q2 2016 | $522,000 | -1.5% | 48,270 | +23.4% | 0.00% | 0.0% |
| Q1 2016 | $530,000 | +76.7% | 39,114 | +140.3% | 0.00% | 0.0% |
| Q4 2015 | $300,000 | – | 16,277 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|